Literature DB >> 2815743

[The most frequent complications during long-term corticotherapy].

R Matusiewicz, M Stempniak, K Lebiedowski, M Czajkowski.   

Abstract

In 274 outpatients with chronic spastic bronchitis long-term treatment with corticosteroids was used due to their clinical condition. In patients treated for 6 years with daily doses of 1-2 mg of prednisolone no corticosteroid-induced complications were observed. Transient ecchymoses occurred in patients treated for longer time periods with prednisolone 4 mg daily. In 12.5% of patients pityriasis versicolor developed, and muscle weakness was the complaint in 3.1% of cases. In patients treated with 6 mg daily of prednisolone petechiae were noted in 35% of cases, in 10% subcutaneous tissue atrophy, in 2.5% osteoporosis was observed, and menstruation disturbances were reported in 25% of the treated women. In patients receiving prednisolone 8 mg daily subcutaneous extravasations developed in 80% of cases, skin atrophy in 50%, myopathy in 25%, crural thrombophlebitis in 5%, cushingoid features in 7.5%. In patients receiving prednisolone 12 mg daily, besides the above complications, fractures occurred in 14.2% of cases, and psychotic symptoms in 7%.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2815743

Source DB:  PubMed          Journal:  Wiad Lek        ISSN: 0043-5147


  2 in total

Review 1.  The coagulation system in endocrine disorders: a narrative review.

Authors:  A Squizzato; V E A Gerdes; W Ageno; H R Büller
Journal:  Intern Emerg Med       Date:  2007-07-09       Impact factor: 3.397

Review 2.  Vive la radiorésistance!: converging research in radiobiology and biogerontology to enhance human radioresistance for deep space exploration and colonization.

Authors:  Franco Cortese; Dmitry Klokov; Andreyan Osipov; Jakub Stefaniak; Alexey Moskalev; Jane Schastnaya; Charles Cantor; Alexander Aliper; Polina Mamoshina; Igor Ushakov; Alex Sapetsky; Quentin Vanhaelen; Irina Alchinova; Mikhail Karganov; Olga Kovalchuk; Ruth Wilkins; Andrey Shtemberg; Marjan Moreels; Sarah Baatout; Evgeny Izumchenko; João Pedro de Magalhães; Artem V Artemov; Sylvain V Costes; Afshin Beheshti; Xiao Wen Mao; Michael J Pecaut; Dmitry Kaminskiy; Ivan V Ozerov; Morten Scheibye-Knudsen; Alex Zhavoronkov
Journal:  Oncotarget       Date:  2018-02-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.